Taken together with our results showed that knockdown of USP5 significantly inhibited the aerobic glycolysis process, further development of USP5 inhibitors to reverse the aerobic glycolysis of cancer cells and reduce cancer progression may contribute to future clinical treatment of cancer. The gene discussed is USP5; the disease is cancer.